Home » Newsletters » BioWorld

BioWorld

June 27, 2001

View Archived Issues

TKT Seeks $88M For Product Development, Clinical Trials

Partnering For Life, And For Value, Make Alliances Work

A Lot Of Action Foreseen On Shortcomings In Patent Office

Other News To Note

Anticipating Xanelim Launch, XOMA Agrees To Raise $43M

Ligand, TAP In 3-Year Androgen Agreement Worth Up To $44M

Cellegy Files NDA On Anogesic Seeking Pain Treatment Review

ICOS Puts $300M On Shelf To Fund Trials, Development

Correction

Patients In Blast-Crisis Stage Of Myelogenous Leukemia Relapse; Original Oncogene Hangs Tough

Europe Seen With Quick Start’ Advantages For New Biotechs

Genomics Will Fragment Industry, Deconsolidation Wave Due Next

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...